Pharmacyclics: Motexafin Gadolinium Pharmacyclics, Inc. is developing biopharmaceutical products designed to improve radiation, chemotherapy and photodynamic therapy of certain cancers, atherosclerotic cardiovascular disease and retinal diseases.
For in the final analysis, our most basic common link, is that we all inhabit
this small planet, we all breathe the same air, we all cherish our children's
futures, and we are all mortal. - John F. Kennedy